DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Software
Author Program NEWCreate Narrative
CLBT logo

Cellebrite DI Ltd. Stock Price

NasdaqGS:CLBT Community·US$3.0b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 47 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

CLBT Share Price Performance

US$11.85
-4.51 (-27.57%)
​
US$15.36
Fair Value
US$11.85
-4.51 (-27.57%)
22.8% undervalued intrinsic discount
US$15.36
Fair Value
Price US$11.85
AnalystConsensusTarget US$15.36
AnalystLowTarget US$15.00
AnalystHighTarget US$28.00
Fri, 14 Aug 26
Fair ValueUS$15.36
Share Pricen/a

CLBT Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$15.36 22.8% undervalued intrinsic discount

Cloud SaaS Solutions Will Drive Digital Forensics Adoption

1users have liked this narrative
0users have commented on this narrative
20users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$15 21.0% undervalued intrinsic discount

Government Delays Will Limit Digital Forensics Efficacy But Boost Resilience

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$28 57.7% undervalued intrinsic discount

Digital Device Growth And Cybercrime Will Transform Investigations

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
CLBT logo
Cellebrite DI
22.8% undervalued intrinsic discount

Cloud SaaS Solutions Will Drive Digital Forensics Adoption

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 14 Aug
Read Narrative
CLBT logo
Cellebrite DI
21.0% undervalued intrinsic discount

Government Delays Will Limit Digital Forensics Efficacy But Boost Resilience

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 19 Jun
Read Narrative
CLBT logo
Cellebrite DI
57.7% undervalued intrinsic discount

Digital Device Growth And Cybercrime Will Transform Investigations

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Published 22 Aug 2025
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
CLBT logo

CLBT: Federal AI And Cloud Demand Will Support Premium Future P/E Potential

Fair Value: US$15.36 22.8% undervalued intrinsic discount
20 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
CLBT logo

CLBT: AI Evidence Platform And Cloud Authorizations Will Shape Earnings Power

Fair Value: US$15 21.0% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
CLBT logo

Digital Device Growth And Cybercrime Will Transform Investigations

Fair Value: US$28 57.7% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

1 Risk
4 Rewards
View Full Analysis

Cellebrite DI Ltd. Key Details

US$514.3m

Revenue

US$87.6m

Cost of Revenue

US$426.7m

Gross Profit

US$368.4m

Other Expenses

US$58.2m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
0.23
82.96%
11.33%
0%
View Full Analysis

About CLBT

Founded
n/a
Employees
1285
CEO
Shiven Ramji
WebsiteView website
www.cellebrite.com

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.

Recent CLBT News & Updates

Seeking Alpha • 4h

Cellebrite: Mobile Forensics Leadership At A Compelling Valuation

Summary Cellebrite offers ~90% recurring revenue and 117% net retention, anchored by mobile forensics leadership and new growth levers. Cellebrite is rated 'Buy' at ~$12, with a Fair Value estimate of $17.3, reflecting ~44% potential upside and a strong GARP profile. I see a narrow moat based on their leadership in mobile forensics, robust rule of X score, and cross-selling opportunities. Risks include quantum disruption, geopolitical exposure in Israel, and device maker advances; conservative scenarios suggest the current valuation is fair. Read the full article on Seeking Alpha

Recent updates

No updates

Cellebrite DI Ltd. Competitors

GWRE logo

Guidewire Software

Symbol: NYSE:GWRE
Market cap: US$17.0b
PTC logo

PTC

Symbol: NasdaqGS:PTC
Market cap: US$16.9b
DT logo

Dynatrace

Symbol: NYSE:DT
Market cap: US$15.8b
AKAM logo

Akamai Technologies

Symbol: NasdaqGS:AKAM
Market cap: US$15.6b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide